Accessibility Menu
Rhelion Life Sciences logo

Rhelion Life Sciences(OTC) TRUFF

Market Cap$13.23MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-68%
5 Year-90%
1 Year-25%
1 Month+3%
$0.02
+1.42%
+0.00Today
Rhelion Life Sciences last closing stock price
MetricPriceDate
Last closeUSD 0.022026-08-28
Rhelion Life Sciences stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.11%USD 0.022026-08-21
1 month+2.57%USD 0.022026-07-29
3 month-27.72%USD 0.032026-05-29
Year to date+32.31%USD 0.022025-12-31
1 year-25.26%USD 0.032025-08-28
3 year-60.84%USD 0.062023-08-29
5 year-89.59%USD 0.212021-08-27
Since inception-68.46%USD 0.072020-07-17

Rhelion Life Sciences Financials at a Glance

Market Cap

$13.23MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$4.19M

Net Income (TTM)

-CA$6.10M

EPS (TTM)

-$0.01

P/E Ratio

-2.03

Dividend

$0.00

Beta (Volatility)

0.52 (Low)

Price

$0.02

Volume

93,022

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.03

52-Week Range

$0.01 - $0.04

Estimated Earnings Date

Aug 31, 2026

TRUFF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Rhelion Life Sciences

Rhelion Life Sciences Corp. is a company focused on the cultivation, manufacturing, and commercialization of magic truffles for the leisure market in the Netherlands. The company also engages in sourcing and distributing a variety of products, including CBD items and cannabis-infused baked goods.

Products and Services
  • Magic truffles for the leisure market
  • CBD products and cannabis seeds
  • Cannabis-infused bakery items like cookies and muffins
Growth Outlook
  • Expansion into international markets is underway
  • Increasing consumer interest in alternative wellness products
  • Plans to enhance e-commerce capabilities for broader reach
Financial Highlights
  • Recent quarterly revenue of CAD 875,322 shows growth potential
  • Cash and short-term investments total CAD 9.05 million
  • Current ratio of 3.98 indicates strong liquidity position
Rhelion Life Sciences Corp. operates in the rapidly evolving drug manufacturing sector, particularly within the specialty and generic categories. The company's focus on magic truffles and related products positions it well to capitalize on the growing demand for alternative wellness solutions. Recent financial data indicates a revenue increase, suggesting a positive trajectory for the company. The strong liquidity position, as evidenced by a current ratio of 3.98, provides a solid foundation for future growth initiatives. With plans for international expansion and enhanced e-commerce capabilities, Rhelion Life Sciences Corp. is poised to leverage market trends effectively.
AI Generated • Aug 28, 2026

Industry

Food Products

Sector

Consumer Staples

CEO

Todd Michael Shapiro

Website

www.redlight.co

Headquarters

Toronto, ON M5C 2V9, CA

TRUFF Financials

Key Financial Metrics (TTM)

Gross Margin

31.66%

Operating Margin

-105.56%

Net Income Margin

-145.45%

Return on Equity

-41.33%

Return on Capital

-30.82%

Return on Assets

-41.88%

Earnings Yield

-49.26%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$13.23MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

614.13M

Volume

93.02K

Avg. Volume

200.13K

Financials (TTM)

Gross Profit

CA$1.51M

Operating Income

-CA$7.82M

EBITDA

-CA$4.20M

Operating Cash Flow

-CA$2.42M

Capital Expenditure

-CA$1.23M

Free Cash Flow

-CA$3.65M

Cash & ST Invst.

CA$9.05M

Total Debt

CA$1.42M

Rhelion Life Sciences Performance Analysis

Rhelion Life Sciences annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31CAD 2,985,64961.0%
20242024-03-31CAD 3,523,03918.0%
20252025-03-31CAD 3,554,7080.9%
20262026-03-31CAD 3,035,512-14.6%
Rhelion Life Sciences sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-3053.2%
Q22025-09-30-42.0%
Q32025-12-3167.6%
Q42026-03-31-30.7%
Rhelion Life Sciences annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31CAD -0.01-66.6%
20242024-03-31CAD -0.0131.2%
20252025-03-31CAD -0.01-49.7%
20262026-03-31CAD -0.0147.2%
Rhelion Life Sciences sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-3016.7%
Q22025-09-30-12.0%
Q32025-12-31-17.9%
Q42026-03-31-84.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

CA$875.32K

+3.1%

Gross Profit

CA$458.57K

+42.5%

Gross Margin

52.39%

N/A

Market Cap

$13.23MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$127.20K

N/A

Employees

104

N/A

Net Income

-CA$2.53M

-110.6%

EBITDA

-CA$1.01M

+14.2%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

CA$9.05M

-26.2%

Total Debt

CA$1.42M

-35.0%

Accounts Receivable

CA$478.51K

+18.3%

Inventory

CA$846.13K

-15.5%

Long Term Debt

CA$223.03K

-30.6%

Short Term Debt

CA$1.20M

-35.8%

Return on Assets

-41.88%

N/A

Return on Invested Capital

-38.70%

N/A

Free Cash Flow

-CA$1.55M

-163.4%

Operating Cash Flow

-CA$460.94K

+16.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MCUJFMedicure Inc.
$1.72+39.84%
MMJJFUnderwood Capital Limited
$0.04+22.70%
UNVCUnivec, Inc.
$0.00+10.71%
UDOCFUnidoc Health Corp.
$0.09-6.22%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$217.55-0.05%
PCGPG&E
$16.60-0.08%
BITOProShares Trust - ProShares Bitcoin ETF
$10.45-0.03%
IRENIren
$35.45-0.13%

Questions About TRUFF

What is the current price of Rhelion Life Sciences?

Rhelion Life Sciences is trading at $0.02 per share.

What is the 52-week range for Rhelion Life Sciences?

Over the past 52 weeks, Rhelion Life Sciences has traded between $0.01 and $0.04.

How much debt does Rhelion Life Sciences have?

As of the most recent reporting period, Rhelion Life Sciences reported total debt of CA$205.40K.

How much cash does Rhelion Life Sciences have on hand?

Rhelion Life Sciences reported CA$6.07M in cash and cash equivalents in its most recent financial results.

What is Rhelion Life Sciences’s dividend yield?

Rhelion Life Sciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services